Immunovaccine Elects Medicago CEO Andy Sheldon as Board Chairman; Reports Results of the Annual General Meeting (AGM)
April 15, 2016 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - April 15, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine Names Frederic Ors Chief Executive Officer; Andy Sheldon, Medicago CEO, to Join Board of Directors
April 13, 2016 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - April 13, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine to Present New Pre-Clinical Data at the 2016 AACR Annual Meeting
April 11, 2016 17:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - April 11, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy...
Immunovaccine and Leidos Join Forces to Develop a Zika Virus Vaccine Candidate
April 07, 2016 07:05 ET
|
Immunovaccine Inc.;Leidos
HALIFAX, NOVA SCOTIA and RESTON, VIRGINIA--(Marketwired - April 7, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and...
Immunovaccine Announces 2015 Year-End Results
March 29, 2016 17:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - March 29, 2016) - Immunovaccine Inc. (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced its financial and...
Immunovaccine Announces Management Team Changes
March 15, 2016 17:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - March 15, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine Initiates Zika Virus Vaccine Program Using Proprietary DepoVax(TM) Platform
March 03, 2016 09:00 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - March 3, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy...
Immunovaccine Announces U.S. FDA, Health Canada Clearance to Initiate Phase 1b Clinical Trial for DPX-Survivac in Combination with Incyte's IDO1 Inhibitor Epacadostat in Recurrent Ovarian Cancer
January 11, 2016 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Jan. 11, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine to Participate in Panel Discussion at Biotech Showcase 2016
January 07, 2016 17:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Jan. 7, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine Publishes Findings Unique to DepoVax(TM) Technology on Potential of MRI Scans to Predict and Optimize Cancer Vaccine Response
December 17, 2015 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Dec. 17, 2015) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...